Teva chief executive Shlomo Yanai speaks during a tour at the company's new distribution centre in
The logo of Croatia's pharmaceutical company Pliva owned by Teva Pharmaceutical Industries is seen in front of the company's building in Zagreb March 18, 2010. Pliva was Croatia's biggest drugs firm in the 1990s and traded on the London Stock ...
Teva sees higher margins, lower debt from restructuring | Financial Times
A man walks past the logo of Teva Pharmaceutical Industries at their plant in Jerusalem December 14, 2017. REUTERS/Ammar Awad Stock Photo - Alamy
Spain's Sabadell expects to hit profitability target a year early | Reuters
AstraZeneca's CEO Soriot to join Israeli drugs company Teva: report By Reuters
Teva settles shareholder lawsuit over generic drug | Business Insurance
Teva Pharmaceuticals at heart of major price fixing suit in US - www.israelhayom.com
Teva, Amgen end dispute over generic Cinacalcet HCl tablets By Reuters
Teva Pharm to lay off a quarter of workforce, suspends dividend By Reuters
Levinstein's purchase of Teva's Jerusalem plant in doubt - Globes
Reuters: U.S. states accuse Teva of price-fixing • Rx|X Consulting
Teva to proceed with Rimsa breach of contract suit after ruling
Allergan to sell a quarter of its Teva stake in first quarter of 2018 | Reuters
Teva chief executive Shlomo Yanai speaks during a tour at the company's new distribution centre in the central Israeli town of Shoham March 1, 2011. Teva Pharmaceutical Industries, the world's largest generics
The logo of Croatia's pharmaceutical company Pliva owned by Teva Pharmaceutical Industries is seen at the top of the company's building in Zagreb March 18, 2010. Pliva was Croatia's biggest drugs firm
California judge rules for Israeli Teva in major opioid lawsuit - The Jerusalem Post
/s3.amazonaws.com/arc-authors/reuters/fe8c4b1b-9993-48e0-872b-a2ef82f39805.png "Teva settles shareholder lawsuit over generic drug pricing for $420 mln | Reuters")
Teva settles shareholder lawsuit over generic drug pricing for $420 mln | Reuters
Teva Pharm to Close Plant in Israel After No Buyer Found
Teva Pharma shares sink as sales forecast disappoints market
Teva tries to clear Allergan deal with $2B more in asset sales: Reuters | FiercePharma
Teva buys Anda for $500 million - ISRAEL21c
